Literature DB >> 982854

Characterization of the immune response to the major glycoprotein (gp 71) of Friend leukemia virus. I. Response in BALB/c mice.

J N Ihle, J J Collins, J C Lee, P J Fischinger, V Moennig, W Schäfer, M G Hanna, D P Bolognesi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 982854     DOI： 10.1016/0042-6822(76)90008-8

Source DB:  PubMed          Journal:  Virology        ISSN： 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  7 in total

1.  Immuno-prophylaxis and -therapy of C-type oncorna viral diseases in mice and cats.

Authors:  W Schäfer; D P Bolognesi; F de Noronha; P J Fischinger; G Hunsmann; J N Ihle; V Moenning; H Schwarz; H J Thiel
Journal:  Med Microbiol Immunol       Date:  1977       Impact factor: 3.402

2.  Effect of chemical modification and fragmentation on antigenic determinants of internal protein p30 and surface glycoprotein gp70 of type C retroviruses.

Authors:  R J Versteegen; S Oroszlan
Journal:  J Virol       Date:  1980-03       Impact factor: 5.103

3.  Radioimmunoassays for the 36,000-dalton glycoprotein of murine mammary tumor viruses demonstrate type, group, and interspecies determinants.

Authors:  Y A Teramoto; J Schlom
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

4.  [Model studies on virus-induced tumors and their immunological treatment (author's transl)].

Authors:  W Schäfer
Journal:  Klin Wochenschr       Date:  1977-09-01

5.  Acquisition of oncogenicity by endogenous mouse type C viruses: effects of variations in env and gag genes.

Authors:  S G Devare; U R Rapp; G J Todaro; J R Stephenson
Journal:  J Virol       Date:  1978-11       Impact factor: 5.103

6.  Type-specific antigenic determinants on the major external glycoprotein of high- and low-oncogenic murine mammary tumor viruses.

Authors:  Y A Teramoto; D Kufe; J Schlom
Journal:  J Virol       Date:  1977-11       Impact factor: 5.103

Review 7.  A New Scientific Paradigm may be Needed to Finally Develop an HIV Vaccine.

Authors:  José Esparza
Journal:  Front Immunol       Date:  2015-03-18       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.